China's BGI And Healthlink Invest And Make Deal With UK's Congenica

Congenica, a Cambridge, UK company that offers clinical genomics interpretation software for inherited diseases, completed a Series B funding from two China-based investors -- BGI Genomics and Healthlink Capital -- along with Future Planet Capital. BGI Genomics and Healthlink also signed up to use Congenica’s enterprise software, Sapientia™, in their China clinical diagnostic labs. Financial details were not disclosed, but Congenica did announce an earlier $10 million closing of its Series B round with other investors in February.